Inappropriate Use of Topical Corticosteroides in the Dermatology Outpatient
- PMID: 34672275
Inappropriate Use of Topical Corticosteroides in the Dermatology Outpatient
Abstract
Introduction: Topical corticosteroids are group of drugs which have anti-in?ammatory, immuno-suppressive, anti-proliferative and vasoconstrictive effects and are among the most commonly prescribed medication, important and efficacious for management of various dermatological disorders. Strict implementation of the existing regulations is the need of the hour to prevent their widespread abuse. Aim of the study was to investigate the usage of topical corticosteroids therapy with the recipe of a doctor and without it.
Subjects and methods: The subjects were patients who visited Pharmacies in Mostar from April to July 2020 and were buying topical corticosteroids with or without a recipe or medical report from the doctor. 80 subjects completed a questionnaire themselves included: the way of buying a topical corticosteroids, the information about using topical corticosteroids earlier, the information about subject's visits to the doctor; the length of time using topical corticosteroids, the type of topical corticosteroids used, the part of body the topical corticosteroids was applied on.
Results: A total of 80 subjects were treated in the observed period, 58.8% were female. 72.5% subjects had already used local corticosteroids, 62.50% purchased the drug at the recommendation of the pharmacist, 66.30% had no recent diagnosis or no diagnosed disease at all, 21.25% used the drug for more than a month, the most often purchased one was moderate potent local corticosteroid Betamethasone diproprionate 0.05%. Most commonly subjects applied local corticosteroids on arms (50%).
Conclusion: Strict regulations regarding only prescription-based dispensing of local corticosteroids must be put into practice. This will hopefully bring down both the extremes of ever increasing cases of steroid-induced dermatoses in everyday dermatology practise on one hand and the irrational fears of using TCs in well justified indications on the other.
Similar articles
-
Prevalence of Misuse of Topical Corticosteroid among Dermatology Outpatients.JNMA J Nepal Med Assoc. 2020 Nov 22;58(231):834-838. doi: 10.31729/jnma.5271. JNMA J Nepal Med Assoc. 2020. PMID: 34506417 Free PMC article.
-
Topical corticosteroids in dermatology.Indian J Dermatol Venereol Leprol. 2016 Jul-Aug;82(4):371-8. doi: 10.4103/0378-6323.178903. Indian J Dermatol Venereol Leprol. 2016. PMID: 27279294 Review.
-
Assessment of information and education about topical corticosteroids in dermatology outpatient departments: experience from Turkey.J Eur Acad Dermatol Venereol. 2003 Nov;17(6):652-8. doi: 10.1046/j.1468-3083.2003.00723.x. J Eur Acad Dermatol Venereol. 2003. PMID: 14761131
-
Prescribing practices of corticosteroids in outpatient dermatology department of Injibara General Hospital, north-West Ethiopia, 2024.Front Med (Lausanne). 2025 Jan 3;11:1496784. doi: 10.3389/fmed.2024.1496784. eCollection 2024. Front Med (Lausanne). 2025. PMID: 39830384 Free PMC article.
-
Clinical potential of topical corticosteroids.Drugs. 1988;36 Suppl 5:38-42. doi: 10.2165/00003495-198800365-00008. Drugs. 1988. PMID: 3076130 Review.
Cited by
-
Management of Atopic Dermatitis: The Role of Tacrolimus.Cureus. 2022 Aug 18;14(8):e28130. doi: 10.7759/cureus.28130. eCollection 2022 Aug. Cureus. 2022. PMID: 35990561 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous